0001193125-24-011699.txt : 20240122 0001193125-24-011699.hdr.sgml : 20240122 20240122080055 ACCESSION NUMBER: 0001193125-24-011699 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 12 CONFORMED PERIOD OF REPORT: 20240116 ITEM INFORMATION: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers FILED AS OF DATE: 20240122 DATE AS OF CHANGE: 20240122 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Apellis Pharmaceuticals, Inc. CENTRAL INDEX KEY: 0001492422 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 271537290 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-38276 FILM NUMBER: 24547114 BUSINESS ADDRESS: STREET 1: 100 FIFTH AVENUE CITY: WALTHAM STATE: MA ZIP: 02451 BUSINESS PHONE: 617-977-5700 MAIL ADDRESS: STREET 1: 100 FIFTH AVENUE CITY: WALTHAM STATE: MA ZIP: 02451 8-K 1 d696780d8k.htm 8-K 8-K
false 0001492422 0001492422 2024-01-16 2024-01-16

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

 

 

FORM 8-K

 

 

CURRENT REPORT

Pursuant to Section 13 or 15(d)

of the Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): January 16, 2024

 

 

Apellis Pharmaceuticals, Inc.

(Exact Name of Registrant as Specified in its Charter)

 

 

 

Delaware   001-38276   27-1537290

(State or Other Jurisdiction

of Incorporation)

  

(Commission

File Number)

  

(IRS Employer

Identification No.)

 

100 Fifth Avenue

Waltham, MA

   02451
(Address of Principal Executive Offices)   (Zip Code)

Registrant’s telephone number, including area code: (617) 977-5700

Not applicable

(Former Name or Former Address, if Changed Since Last Report)

 

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

 

  ☐

Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

  ☐

Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

  ☐

Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

  ☐

Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

 

Title of each class

  

Trading

Symbol(s)

  

Name of each exchange

on which registered

Common Stock   APLS   Nasdaq Global Select Market

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

 

 

 

Item 5.02

Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.

On January 16, 2024, the Board of Directors of Apellis Pharmaceuticals, Inc. (the “Company”) appointed Adam Townsend, the Company’s Chief Commercial Officer, to serve as the Company’s Chief Operating Officer, effective immediately.

Mr. Townsend, 47, has served as the Company’s Chief Commercial Officer since November 2018. From March 2010 to October 2018 he served in a variety of leadership roles at Biogen, including as Senior Vice President of Corporate Development from March 2018 to October 2018, as Senior Vice President, Specialty Medicines and Rare Disease Group from April 2017 to March 2018, as Vice President, Asset Executive for Spinraza from May 2016 to April 2017, Vice President – Account Executive for Hemophilia from November 2015 to May 2016, and Vice President Global Marketing – Head of Multiple Sclerosis from July 2013 to November 2015. Mr. Townsend received his medical biochemistry degree from Royal Holloway, University of London.

Mr. Townsend has no family relationships with any of the Company’s directors or executive officers. There are no transactions and no proposed transactions between Mr. Townsend and the Company that would be required to be disclosed pursuant to Item 404(a) of Regulation S-K.

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

  Apellis Pharmaceuticals, Inc.
Date: January 22, 2024     By:  

/s/ Timothy Sullivan

      Timothy Sullivan
      Chief Financial Officer
 EX-101.SCH 2 apls-20240116.xsd XBRL TAXONOMY EXTENSION SCHEMA 100000 - Document - Document and Entity Information link:calculationLink link:presentationLink link:definitionLink EX-101.LAB 3 apls-20240116_lab.xml XBRL TAXONOMY EXTENSION LABEL LINKBASE Cover [Abstract] Cover [Abstract] Amendment Flag Amendment Flag Entity Central Index Key Entity Central Index Key Document Type Document Type Document Period End Date Document Period End Date Entity Registrant Name Entity Registrant Name Entity Incorporation State Country Code Entity Incorporation State Country Code Entity File Number Entity File Number Entity Tax Identification Number Entity Tax Identification Number Entity Address, Address Line One Entity Address, Address Line One Entity Address, City or Town Entity Address, City or Town Entity Address, State or Province Entity Address, State or Province Entity Address, Postal Zip Code Entity Address, Postal Zip Code City Area Code City Area Code Local Phone Number Local Phone Number Written Communications Written Communications Soliciting Material Soliciting Material Pre Commencement Tender Offer Pre Commencement Tender Offer Pre Commencement Issuer Tender Offer Pre Commencement Issuer Tender Offer Security 12b Title Security 12b Title Trading Symbol Trading Symbol Security Exchange Name Security Exchange Name Entity Emerging Growth Company Entity Emerging Growth Company EX-101.PRE 4 apls-20240116_pre.xml XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE XML 5 R1.htm IDEA: XBRL DOCUMENT v3.23.4
Document and Entity Information
Jan. 16, 2024
Cover [Abstract]  
Amendment Flag false
Entity Central Index Key 0001492422
Document Type 8-K
Document Period End Date Jan. 16, 2024
Entity Registrant Name Apellis Pharmaceuticals, Inc.
Entity Incorporation State Country Code DE
Entity File Number 001-38276
Entity Tax Identification Number 27-1537290
Entity Address, Address Line One 100 Fifth Avenue
Entity Address, City or Town Waltham
Entity Address, State or Province MA
Entity Address, Postal Zip Code 02451
City Area Code (617)
Local Phone Number 977-5700
Written Communications false
Soliciting Material false
Pre Commencement Tender Offer false
Pre Commencement Issuer Tender Offer false
Security 12b Title Common Stock
Trading Symbol APLS
Security Exchange Name NASDAQ
Entity Emerging Growth Company false
XML 6 d696780d8k_htm.xml IDEA: XBRL DOCUMENT 0001492422 2024-01-16 2024-01-16 false 0001492422 8-K 2024-01-16 Apellis Pharmaceuticals, Inc. DE 001-38276 27-1537290 100 Fifth Avenue Waltham MA 02451 (617) 977-5700 false false false false Common Stock APLS NASDAQ false EXCEL 7 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx M4$L#!!0 ( !I -E@'04UB@0 +$ 0 9&]C4')O<',O87!P+GAM M;$V./0L",1!$_\IQO;=!P4)B0-!2L+(/>QLOD&1#LD)^OCG!CVX>;QA&WPIG M*N*I#BV&5(_C(I(/ !47BK9.7:=N')=HI6-Y #OGDK7A.YNJQ<&4GPZ4A!0W_J=0U[R;UEA_6\#MI7E!+ P04 M " :0#98F>*HS>X K @ $0 &1O8U!R;W!S+V-O&ULS9+! M2L0P$(9?17)O)TW50^CFHGA2$%Q0O(5D=C?8I"$9:??M;>-N%]$'\)B9/]]\ M ].9*,V0\#D-$1,YS%>3[T.6)F[8@2A*@&P.Z'6NYT28F[LA>4WS,^TA:O.A M]PB"\UOP2-IJTK J[@2F>JLD2:AIB&=\-:L^/B9^@*S!K!'CX$R-'4#3"T3 MXW'J.[@ %AAA\OF[@'8EENJ?V-(!=DI.V:VI<1SKL2VY>8<&WIX>7\JZE0N9 M=# X_\I.TC'BAITGO[9W]]L'I@07UQ5O*B&V32LYES?B?7']X7<1]H-U._>/ MC<^"JH-?=Z&^ %!+ P04 " :0#98F5R<(Q & "<)P $P 'AL+W1H M96UE+W1H96UE,2YX;6SM6EMSVC@4?N^OT'AG]FT+QC:!MK03621A'^_1S80RY8-[9)-NIL\!"SI^\Y%1^?H.'GS[BYBZ(:(E/)X M8-DOV]:[MR_>X%#BVR]*+ M41B1%G\@M MNN01.+5)#3(3/PB=AIAJ4!P"I DQEJ&&^+3&K!'@$WVWO@C(WXV(]ZMOFCU7 MH5A)VH3X$$8:XIQSYG/1;/L'I4;1]E6\W*.76!4!EQC?-*HU+,76>)7 \:V< M/!T3$LV4"P9!AI@S M&L%&KQMUAVC2/'K^!?F<-0HACA*FNVB<5@$_9Y>PTG!Z(++9OVX?H;5,VPLCO='U!=*Y \FIS_I,C0' MHYI9";V$5FJ?JH,@H%\;D>/N5Z> HWEL:\4*Z">P'_T=HWPJOX@L Y M?RY]SZ7ON?0]H=*W-R-]9\'3BUO>1FY;Q/NN,=K7-"XH8U=RSTS0LS0[=R2^JVE+ZU)CA* M]+',<$X>RPP[9SR2';9WH!TU^_9==N0CI3!3ET.X&D*^ VVZG=PZ.)Z8D;D* MTU*0;\/YZ<5X&N(YV02Y?9A7;>?8T='[Y\%1L*/O/)8=QXCRHB'NH8:8S\-# MAWE[7YAGE<90-!1M;*PD+$:W8+C7\2P4X&1@+: '@Z]1 O)256 Q6\8#*Y"B M?$R,1>APYY=<7^/1DN/;IF6U;J\I=QEM(E(YPFF8$V>KRMYEL<%5'<]56_*P MOFH]M!5.S_Y9KF4Q9Z;RWRT,"2Q;B%D2XDU=[=7GFYRN>B)V^I=W MP6#R_7#)1P_E.^=?]%U#KG[VW>/Z;I,[2$R<><41 71% B.5' 86%S+D4.Z2 MD 83 >LX=SFWJXPD6L_UC6'ODRWSEPVSK> U[F M$RQ#I'[!?8J*@!&K8KZZKT_Y)9P[M'OQ@2";_-;;I/;=X Q\U*M:I60K$3]+ M!WP?D@9CC%OT-%^/%&*MIK&MQMHQ#'F 6/,,H68XWX=%FAHSU8NL.8T*;T'5 M0.4_V]0-:/8--!R1!5XQF;8VH^1."CS<_N\-L,+$CN'MB[\!4$L#!!0 ( M !I -E@9^A3!/ 0 '@0 8 >&PO=V]R:W-H965T&UL MC9AO;ZLV%,:_BL6D:9-N"W;^-5T2B:;MUMVV-[?I5FG37CC@)%;!9L8TS;?? M,4DA=Y<<\J;!P'GXV>?XL=W11IO7?"V$)>]IHO*QM[8VN_3]/%J+E.?G.A,* MGBRU2;F%IEGY>68$C\N@-/%9$/3]E$OE34;EO9F9C'1A$ZG$S)"\2%-NMEA4=BL>1%8I_TYC>Q[U#/Z44ZRT_XFP@'6_#?>!K0)D%2 K]3I']*;Z31CR=[C(K8$4_M-$M%/H M-BNXNK[,,QZ)L0>%FPOS)KS)CS_0?O +PM>I^#J8^B2$T8O+$;Q-^*J)#H]? M\B07"$>WXNBB.OO<38'$\ 1R&(MW\EELFXAPI2 (:'?(NHPA6+T*JX>*5?7U MO,U$$PL>?G'V&8'H5Q#]TR!FPDCMZCPF,%L:>7"EJKK;RGM0H0U.2=N36$E7 MX,#XR--&,%PGS,#89$YF:PY3-Q*%E1%4UB2Q2!?"-('@&E#U9YT+-N@C M/#2H;34XA>B9OY.[&$I/+B$?Y: =YVN19(,SVNL,V## " ^,GYY"&,8QF"(4 MROZ"W,-[Y(MJ3&6+) T"R,'2KDGX)E2!V1JM_9^B]OT=Y]2UM"'/>M.\/.%R M+SRQ:YYB:+7U4]R[_X^VFP_ -C/Z3:JH>0QQS8<00ZM7 WK2OU@.)&_F*DM4+!T*1IH?:FD3=2X4)M&PM:6S_%+7JN M$QE)*]6*/$"!&\F31AYX17]'=I?G!9"U ;;(M@+6IL]PAYZ+J#!N^E&V(,_2)HW3KT7$];!< M_77TBE$=;/%Q3WXV/';5-=^F"]U86RT"X>Q^CI'4CLYP]ZW&Y^8]6G.U$D>W M8RU"C^'\.OR*,=56SDZR\IM4F)4;I5]! 998R$+&5>/^OD7P:#GY!^=(=R9_ MX.Z+.4G$$H2"\P'8LMD=5:<"AU]P(\7VIM/QKNM%K] MLV'R'U!+ P04 " :0#98GZ ;\+$" #B# #0 'AL+W-T>6QEO%DN7/ZZZ>S;"=I M=67=A['-HN6/O.-%Q[ MI#)6,>=56R=M8SDK6W!2,EG>W&2)8D+38JT[=:=<2PZFTVY#;VA2K"NCSY:4 M!H-?RA0GCTQNZ)9)L;=B6,N4D*=@7H+A8*2QQ'DJ?$,78&F? KP(&K XU7=>&18/QA<0&>7=J?$,:\M. MB^4M/3L,/S[)WMB2VSG-@DZF8BUY!72LJ(_PZTR3 .B<45XH!:N-9@.'R6,4 M?-@#E_(!6OBMNHK=5R3TXE,);2"PU4GTA$8QA D*Q+^,%F)?A+W]K;"D$8_& M?>S\;O2@?^^,X_>65Z(?]+Z:\V/1%WATUC3R]$&*6BL>]O[+"8LUF_S(T5CQ MY+/!I!R\@5M*'KEUXG!I^6%9L^.]FZ:IKW#.RW^0\Y^M<\TUMTQ>DO:C_S=7 M^2V,D_'T7!S1JP,Z6PEY7>>9 ]IV03NA1.XJRY/K%.?7A'=O["_PJ MOE]?\HIUTNUF<$//\A=>BD[E\ZI[J,NXZBQ_AOMHD\%G'!QR>(W?#$T% M^@2O&+(=/EB>N$_NG_A.\SQ-LPRKZ'8;9;#%ZI9E\!>/AG$##RP/9'I;K?%N MXQ/R^AQ@/7UM0K"=XI.([12O-2#QNH%'GL>[C>4!#ZP+V.Q _G@>F*FX3YI" M5S%NV G&D3S'$)C%^(QF&5*=##[Q_F"G)$WS/(X %F>0IA@"IQ%', ; 4/2 M='@//GL?)=-[*CG_5U/\!%!+ P04 " :0#98EXJ[', 3 @ "P M %]R96QS+RYR96QSG9*Y;L,P#$!_Q=">, ?0(8@S9?$6!/D!5J(/V!(%BD6= MOZ_:I7&0"QEY/3P2W!YI0.TXI+:+J1C]$%)I6M6X 4BV)8]ISI%"KM0L'C6' MTD!$VV-#L%HL/D N&6:WO606IW.D5XA-/E_G;@2=&A(E@6FD7)TZ(=I7\=Q_:0T^FO8R*T M>EOH^7%H5 J.W&,EC'%BM/XU@LD/['X 4$L#!!0 ( !I -E@<.&7J/P$ M #P" / >&PO=V]R:V)O;VLN>&ULC5'+;L) #/R5U7Y $U"+5$2XE#Z0 MJA:5BON2=8C%/B*O RU?7R=15*1>>O)Z;(UG9A?G2,=]C$?UY5U(A:Z9FWF6 MI;(&;])-;"#(I(KD#4M+ARPU!,:F&H"]RZ9Y/LN\P:"7BY%K0]EU$QE*QA@$ M[( =PCG]SKM6G3#A'AWR=Z'[MP.M/ ;T> %;Z%RK5,?S2R2\Q,#&;4N*SA5Z M,@QV0(SE'WC;B?PT^]0C;/8?1H04>I8+8864N-_H^8UH/($L#UW+\0D= ZT, MPS/%ML%PZ&C$179EH\]AK$.(<_I/C+&JL(15+%L/@8<<"5PG,*0:FZ15,!X* M/:XH$ZQZ#"PAJ748J&2WEYIK=WDWM)J'7N0;#W\!J-'[IFB MG#S^0W1UW6E\./VR./ /,+Q=Z*E%9"E*%1KD3,)HMC;!4N++3):BJ#(9BBJ6 M<%H@XLD@;6E6?;!/3K3G>1,)KM\,<'AT_@%02P,$% @ &D V M6&60>9(9 0 SP, !, !;0V]N=&5N=%]4>7!E&ULK9--3L,P$(6O M$F5;)2XL6*"F&V +77 !8T\:J_Z39UK2VS-.VDJ@$A6%3:QXWKS/GI>LWH\1 ML.B=]=B4'5%\% )5!TYB'2)XKK0A.4G\FK8B2K636Q#WR^6#4,$3>*HH>Y3K MU3.T.EY&TWP39G 8ED\C<+,:DH9HS5*$M?%P>L?E.I$J+EST&!G(BY8 M4(JKA%SY'7#J>SM 2D9#L9&)7J5CE>BM0#I:P'K:XLH90]L:!3JHO>.6&F," MJ;$#(&?KT70Q32:>,(S/N]G\P68*R,I-"A$YL01_QYTCR=U59"-(9*:O>"&R M]>S[04Y;@[Z1S>/]#&DWY(%B6.;/^'O&%_\;SO$1PNZ_/[&\UDX:?^:+X3]> M?P%02P$"% ,4 " :0#98!T%-8H$ "Q $ @ $ M 9&]C4')O<',O87!P+GAM;%!+ 0(4 Q0 ( !I -EB9XJC-[@ "L" M 1 " :\ !D;V-0&UL4$L! A0#% @ &D V6!GZ%,$\! >! !@ M ("!#0@ 'AL+W=O7!E&UL4$L%!@ ) - D /@( -\3 $! end XML 8 Show.js IDEA: XBRL DOCUMENT // Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission. Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105. var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0); e.removeAttribute('id');a.parentNode.appendChild(e)}} if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'} e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}} XML 9 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 10 FilingSummary.xml IDEA: XBRL DOCUMENT 3.23.4 html 1 22 1 false 0 0 false 0 false false R1.htm 100000 - Document - Document and Entity Information Sheet http://www.apellis.com//20240116/taxonomy/role/DocumentDocumentAndEntityInformation Document and Entity Information Cover 1 false false All Reports Book All Reports apls-20240116.xsd apls-20240116_lab.xml apls-20240116_pre.xml d696780d8k.htm http://xbrl.sec.gov/dei/2023 true false JSON 12 MetaLinks.json IDEA: XBRL DOCUMENT { "version": "2.2", "instance": { "d696780d8k.htm": { "nsprefix": "apls", "nsuri": "http://www.apellis.com/20240116", "dts": { "schema": { "local": [ "apls-20240116.xsd" ], "remote": [ "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd", "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd", "http://www.xbrl.org/2003/xl-2003-12-31.xsd", "http://www.xbrl.org/2003/xlink-2003-12-31.xsd", "http://www.xbrl.org/2005/xbrldt-2005.xsd", "http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd", "http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd", "https://www.xbrl.org/dtr/type/2022-03-31/types.xsd", "https://xbrl.sec.gov/dei/2023/dei-2023.xsd", "https://xbrl.sec.gov/naics/2023/naics-2023.xsd" ] }, "labelLink": { "local": [ "apls-20240116_lab.xml" ] }, "presentationLink": { "local": [ "apls-20240116_pre.xml" ] }, "inline": { "local": [ "d696780d8k.htm" ] } }, "keyStandard": 22, "keyCustom": 0, "axisStandard": 0, "axisCustom": 0, "memberStandard": 0, "memberCustom": 0, "hidden": { "total": 2, "http://xbrl.sec.gov/dei/2023": 2 }, "contextCount": 1, "entityCount": 1, "segmentCount": 0, "elementCount": 23, "unitCount": 0, "baseTaxonomies": { "http://xbrl.sec.gov/dei/2023": 22 }, "report": { "R1": { "role": "http://www.apellis.com//20240116/taxonomy/role/DocumentDocumentAndEntityInformation", "longName": "100000 - Document - Document and Entity Information", "shortName": "Document and Entity Information", "isDefault": "true", "groupType": "document", "subGroupType": "", "menuCat": "Cover", "order": "1", "firstAnchor": { "contextRef": "duration_2024-01-16_to_2024-01-16", "name": "dei:DocumentType", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "p", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "d696780d8k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "duration_2024-01-16_to_2024-01-16", "name": "dei:DocumentType", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "p", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "d696780d8k.htm", "first": true, "unique": true } } }, "tag": { "dei_SecurityExchangeName": { "xbrltype": "edgarExchangeCodeItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "SecurityExchangeName", "presentation": [ "http://www.apellis.com//20240116/taxonomy/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Security Exchange Name", "terseLabel": "Security Exchange Name", "documentation": "Name of the Exchange on which a security is registered." } } }, "auth_ref": [ "r2" ] }, "dei_EntityEmergingGrowthCompany": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityEmergingGrowthCompany", "presentation": [ "http://www.apellis.com//20240116/taxonomy/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity Emerging Growth Company", "terseLabel": "Entity Emerging Growth Company", "documentation": "Indicate if registrant meets the emerging growth company criteria." } } }, "auth_ref": [ "r1" ] }, "dei_AmendmentFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "AmendmentFlag", "presentation": [ "http://www.apellis.com//20240116/taxonomy/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Amendment Flag", "terseLabel": "Amendment Flag", "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission." } } }, "auth_ref": [] }, "dei_DocumentPeriodEndDate": { "xbrltype": "dateItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentPeriodEndDate", "presentation": [ "http://www.apellis.com//20240116/taxonomy/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Document Period End Date", "terseLabel": "Document Period End Date", "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD." } } }, "auth_ref": [] }, "dei_CoverAbstract": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "CoverAbstract", "lang": { "en-us": { "role": { "label": "Cover [Abstract]", "terseLabel": "Cover [Abstract]", "documentation": "Cover page." } } }, "auth_ref": [] }, "dei_LocalPhoneNumber": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "LocalPhoneNumber", "presentation": [ "http://www.apellis.com//20240116/taxonomy/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Local Phone Number", "terseLabel": "Local Phone Number", "documentation": "Local phone number for entity." } } }, "auth_ref": [] }, "dei_EntityAddressPostalZipCode": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressPostalZipCode", "presentation": [ "http://www.apellis.com//20240116/taxonomy/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity Address, Postal Zip Code", "terseLabel": "Entity Address, Postal Zip Code", "documentation": "Code for the postal or zip code" } } }, "auth_ref": [] }, "dei_EntityRegistrantName": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityRegistrantName", "presentation": [ "http://www.apellis.com//20240116/taxonomy/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity Registrant Name", "terseLabel": "Entity Registrant Name", "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC." } } }, "auth_ref": [ "r1" ] }, "dei_CityAreaCode": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "CityAreaCode", "presentation": [ "http://www.apellis.com//20240116/taxonomy/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "City Area Code", "terseLabel": "City Area Code", "documentation": "Area code of city" } } }, "auth_ref": [] }, "dei_EntityAddressCityOrTown": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressCityOrTown", "presentation": [ "http://www.apellis.com//20240116/taxonomy/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity Address, City or Town", "terseLabel": "Entity Address, City or Town", "documentation": "Name of the City or Town" } } }, "auth_ref": [] }, "dei_EntityAddressAddressLine1": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressAddressLine1", "presentation": [ "http://www.apellis.com//20240116/taxonomy/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity Address, Address Line One", "terseLabel": "Entity Address, Address Line One", "documentation": "Address Line 1 such as Attn, Building Name, Street Name" } } }, "auth_ref": [] }, "dei_TradingSymbol": { "xbrltype": "tradingSymbolItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "TradingSymbol", "presentation": [ "http://www.apellis.com//20240116/taxonomy/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Trading Symbol", "terseLabel": "Trading Symbol", "documentation": "Trading symbol of an instrument as listed on an exchange." } } }, "auth_ref": [] }, "dei_EntityIncorporationStateCountryCode": { "xbrltype": "edgarStateCountryItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityIncorporationStateCountryCode", "presentation": [ "http://www.apellis.com//20240116/taxonomy/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity Incorporation State Country Code", "terseLabel": "Entity Incorporation State Country Code", "documentation": "Two-character EDGAR code representing the state or country of incorporation." } } }, "auth_ref": [] }, "dei_SolicitingMaterial": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "SolicitingMaterial", "presentation": [ "http://www.apellis.com//20240116/taxonomy/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Soliciting Material", "terseLabel": "Soliciting Material", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act." } } }, "auth_ref": [ "r5" ] }, "dei_EntityTaxIdentificationNumber": { "xbrltype": "employerIdItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityTaxIdentificationNumber", "presentation": [ "http://www.apellis.com//20240116/taxonomy/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity Tax Identification Number", "terseLabel": "Entity Tax Identification Number", "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS." } } }, "auth_ref": [ "r1" ] }, "dei_EntityAddressStateOrProvince": { "xbrltype": "stateOrProvinceItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressStateOrProvince", "presentation": [ "http://www.apellis.com//20240116/taxonomy/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity Address, State or Province", "terseLabel": "Entity Address, State or Province", "documentation": "Name of the state or province." } } }, "auth_ref": [] }, "dei_PreCommencementTenderOffer": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "PreCommencementTenderOffer", "presentation": [ "http://www.apellis.com//20240116/taxonomy/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Pre Commencement Tender Offer", "terseLabel": "Pre Commencement Tender Offer", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act." } } }, "auth_ref": [ "r4" ] }, "dei_Security12bTitle": { "xbrltype": "securityTitleItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "Security12bTitle", "presentation": [ "http://www.apellis.com//20240116/taxonomy/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Security 12b Title", "terseLabel": "Security 12b Title", "documentation": "Title of a 12(b) registered security." } } }, "auth_ref": [ "r0" ] }, "dei_PreCommencementIssuerTenderOffer": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "PreCommencementIssuerTenderOffer", "presentation": [ "http://www.apellis.com//20240116/taxonomy/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Pre Commencement Issuer Tender Offer", "terseLabel": "Pre Commencement Issuer Tender Offer", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act." } } }, "auth_ref": [ "r3" ] }, "dei_WrittenCommunications": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "WrittenCommunications", "presentation": [ "http://www.apellis.com//20240116/taxonomy/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Written Communications", "terseLabel": "Written Communications", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act." } } }, "auth_ref": [ "r6" ] }, "dei_EntityCentralIndexKey": { "xbrltype": "centralIndexKeyItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityCentralIndexKey", "presentation": [ "http://www.apellis.com//20240116/taxonomy/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity Central Index Key", "terseLabel": "Entity Central Index Key", "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK." } } }, "auth_ref": [ "r1" ] }, "dei_EntityFileNumber": { "xbrltype": "fileNumberItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityFileNumber", "presentation": [ "http://www.apellis.com//20240116/taxonomy/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity File Number", "terseLabel": "Entity File Number", "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen." } } }, "auth_ref": [] }, "dei_DocumentType": { "xbrltype": "submissionTypeItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentType", "presentation": [ "http://www.apellis.com//20240116/taxonomy/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Document Type", "terseLabel": "Document Type", "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'." } } }, "auth_ref": [] } } } }, "std_ref": { "r0": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "b" }, "r1": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "b-2" }, "r2": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "d1-1" }, "r3": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "13e", "Subsection": "4c" }, "r4": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "14d", "Subsection": "2b" }, "r5": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Section": "14a", "Number": "240", "Subsection": "12" }, "r6": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Securities Act", "Number": "230", "Section": "425" } } } ZIP 13 0001193125-24-011699-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001193125-24-011699-xbrl.zip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